<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forty two patients who were seen and satisfied the French-American-British (FAB) diagnostic criteria for <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) over a 6-year period at the University of Zimbabwe's Department of Haematology, Harare, are presented </plain></SENT>
<SENT sid="1" pm="."><plain>Their overall ages ranged from 29 to 75 years with a mean +/- SD of 57.8 +/- 11.2 years </plain></SENT>
<SENT sid="2" pm="."><plain>Males outnumbered females with a male to female ratio of 1.2:1 </plain></SENT>
<SENT sid="3" pm="."><plain>Refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA) occurred in 33.3%; refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ringed sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>) in 16.7%; refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) in 21.4%; refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>) in 16.7% and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) in 11.9% of the patients </plain></SENT>
<SENT sid="4" pm="."><plain>In 90.5% the disease was primary and in 9.5% prior exposure to myelotoxic agents resulted in <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The study reveals that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> as a cause of <z:hpo ids='HP_0001903'>anaemia</z:hpo> in the African population is usually hidden in the big number of well known <z:hpo ids='HP_0001903'>anaemias</z:hpo> due to rampant <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>, <z:hpo ids='HP_0004395'>malnutrition</z:hpo> and a host of <z:e sem="disease" ids="C0267975" disease_type="Disease or Syndrome" abbrv="">nutritional deficiencies</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>There is therefore the need to increase diagnostic awareness among our clinicians about the existence of these disorders </plain></SENT>
</text></document>